The life-sciences industry has long been synonymous with high barriers to entry. Traditional research and development (R&D) models demand enormous capital investment, specialized infrastructure, and a deep understanding of regulatory compliance. For startups and innovators, these requirements often translate into years of fundraising and risk before a single product reaches the market. However, the emergence [...]The post The Rise of Bio-Incubator Spaces: Redefining Asset Development in Life Sciences appeared first on Lachman Consultant Services, Inc..